{
    "medicine_id": "e36d781b472c07bbdc30ab5b2ae4415c759f5294",
    "platform_id": "DB00992",
    "metadata": {
        "name": "Metvix 160 mg g Cream",
        "composition": "160 mg g Methyl aminolevulinate",
        "clinical_particulars": {
            "therapeutic_indications": "For topical use in combination with 570 to 670 nm wavelength red light illumination in the treatment of non hyperkeratotic actinic keratoses of the face and scalp in immunocompetent patients when used in conjunction with lesion preparation debridement using a sharp dermal curette",
            "contraindications": {
                "disease": "The severity of local phototoxic reactions such as erythema pain and burning sensation may increase in case of prolonged application time or very high light intensity",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "After topical application of methyl aminolevulinate porphyrins will accumulate intracellularly in the treated skin lesions The intracellular porphyrins including PpIX are photoactive fluorescing compounds and upon light activation in the presence of oxygen singlet oxygen is formed which causes damage to cellular compartments in particular the mitochondria Light activation of accumulated porphyrins leads to a photochemical reaction and thereby phototoxicity to the light exposed target cells",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Tretinoin is combined with Methyl aminolevulinate"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}